Effectiveness and Safety of Morphine Sulfate Extended-Release Capsules in Patients With Chronic, Moderate-To-Severe Pain in a Primary Care Setting

Journal of Pain Research - New Zealand
doi 10.2147/jpr.s23024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Extended-Release Morphine Sulfate in Treatment of Severe Acute and Chronic Pain

Journal of Pain Research
AnesthesiologyPain Medicine
2010English

Rethinking Chronic Pain in a Primary Care Setting

Postgraduate Medicine
Medicine
2016English

Efficacy and Safety of Morphine Hydrochloride in Cancer Patients With Chronic Pain

Siberian Journal of Oncology
Cancer ResearchOncology
2019English

Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain

Pain Practice
AnesthesiologyPain Medicine
2016English

Analgesic and Hemodynamic Effects of a Single 7.5-Mg Intravenous Dose of Morphine in Patients With Moderate-To-Severe Postoperative Pain

Pharmacotherapy
Pharmacology
2004English

PSY5 a Systematic Review of Tapentadol in Chronic Moderate to Severe Pain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

A Multicenter, Open-Label Study of Tapentadol Extended-Release Tablets in Opioid-Naïve and Opioid-Switching Subjects With Moderate to Severe Cancer Pain

Palliative Care Research
2016English

(382) Safety and Tolerability of CNTX-4975 in Subjects With Chronic, Moderate to Severe Knee Pain Associated With Osteoarthritis (OA): A Pilot Study

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2017English

The SPADE Symptom Cluster in Primary Care Patients With Chronic Pain

Clinical Journal of Pain
NeurologyAnesthesiologyPain Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy